期刊文献+

利福平耐药实时荧光定量核酸扩增检测技术与γ-干扰素释放试验在关节结核辅助诊断中的价值 被引量:10

Diagnositic value of Xpert mycobacterium tuberculosis/rifampicin assay and γ-interferon release assay for joint tuberculosis
下载PDF
导出
摘要 目的探讨和评价利福平耐药实时荧光定量核酸扩增检测技术(Xpert mycobacterium tuberculosis/rifampicin,Xpert MTB/RIF;简称Xpert检测)与γ-干扰素释放试验在关节结核辅助诊断中的价值。方法选取2015年1~9月首都医科大学附属北京胸科医院住院经手术治疗,病理确诊为关节结核的患者50例,同时行脓液Xpert检测和血酶联免疫斑点技术法(T-SPOT.TB检测)检测结核分枝杆菌感染T细胞。结果 T-SPOT.TB检测在诊断关节结核中的敏感度为88%(44/50);Xpert检测的敏感度为66%(33/50);两种方法联合检测的敏感度为66%(33/50)。T-SPOT.TB检测的敏感度高于Xpert检测及两种方法联合检测(χ~2=6.832,P=0.009)。结论 Xpert检测和γ-干扰素释放试验采用T-SPOT.TB检测试剂盒在关节结核快速诊断方面均具有重要的价值,两者结合可提高关节结核诊断的准确度。 Objective To explore and evaluate the diagnositic value of Xpert mycobacterium tuberculosis/rifampicin(Xpert MTB/RIF) and γ-interferon release assays in joint tuberculosis. Method 50 patients diagnosed as joint tuberculosis from January 2015 to September 2015 in Capital Medical University, Beijing Chest Hospital were included into this study. Rifampin puss simultaneously real-time quantitative nucleic acid amplification Xpert MTB/RIF and T-SPOT.TB test were tested at the same time. Result T-SPOT.TB detection sensitivity in the diagnosis of joint tuberculosis was 88%(44/50); Xpert detection sensitivity was 66%(33/50); combined detection sensitivity of the two methods was 66%(33/50). T-SPOT.TB sensitivity is higher than Xpert detection and combined detection of the two methods(χ~2=6.832, P = 0.009). Conclusion The Xpert MTB/RIF and γ-interferon release assay which applied by T-SPOT.TB detection method have significant value in the rapid diagnosis of tuberculosis joints. A combination of these can improve the accuracy of joint tuberculosis diagnosis.
出处 《中国医刊》 CAS 2016年第6期70-72,共3页 Chinese Journal of Medicine
基金 北京市医院管理局临床医学发展专项(ZYLX201304)
关键词 利福平耐药实时荧光定量核酸扩增检测技术 Γ-干扰素释放试验 T-SPOT.TB检测 关节结核 诊断 Xpert mycobacterium tuberculosis/rifampicin γ-interferon release assay T-SPOT.TB test Joint tuberculosis Diagnosis
  • 相关文献

参考文献17

  • 1卫生部疾病预防控制局,卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南(2008年版)[M].北京:中国协和医科大学出版社,2009:14-18.
  • 2马玛,朱莉贞,潘毓萱.结核病[M].北京:人民卫生出版社,2006:289.
  • 3秦世炳.我国骨关节结核诊治的回顾与展望[J].中国防痨杂志,2014,36(9):788-792. 被引量:25
  • 4WHO. Policy statement: Xpert MTB/RIFsystem[EB/OL]. WHO/ HTM/TB/2011.4.
  • 5Dillon DC, Alderson MR, Day CH, et al. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, animmunodiagnostic antigen missing in Mycobacterium bovis BCG[J]. J Clin Microbiol, 2000, 38(9):3285-3290.
  • 6Blakemore R, Story E, Helb D, ct al. Evaluation of the analytical performance of the Xpert MTB/RIFassay[J]. J Clin Microboil, 2010, 48(7):2495-2501.
  • 7Ellis ME, et-Ramahi KM, al-Dalaan AN. Tuberculosis of peripheral joints: a dilemma in diagnosis[J]. Tuberc Lung Dis, 1993, 74(6):399-404.
  • 8Sequeira W, Co H, Block JA. Osteoarticular tuberculosis: current diagnosis and treatment[J]. Am J Ther, 2000(7):393-398.
  • 9符艳,蒋正华.结核免疫斑点试验与结核菌素试验在活动性结核病诊断中的优越性对比[J].中国医刊,2015,50(8):54-57. 被引量:22
  • 10唐神结.结核病临床诊治进展年度报告(2014)[M].北京:人民卫生出版社,2014.51-68.

二级参考文献77

共引文献223

同被引文献54

引证文献10

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部